- Congressman: McAuliffe victory means gun control a winning message
- Clinton aide admits soliciting disgraced D.C. fundraiser; says actions were legal
- Joel Osteen church victimized in $600K theft
- Obama goes shopping at Gap as minimum-wage thanks
- N.J. woman charged after client dies from black-market butt injections
- CIA chief Brennan ‘determined’ to speak out more this year
- Reset? What reset? U.S.-Russia ties at worst since Cold War
- 9/11 terror recruiter released in Syrian prisoner swap
- D.C. elections board gives green light to marijuana legalization initiative
- Elephants can tell difference between human languages: study
Preemie birth preventive spikes from $10 to $1,500
ATLANTA (AP) - The price of preventing preterm labor is about to go through the roof.
A drug for high-risk pregnant women has cost about $10 to $20 per injection. Next week, the price shoots up to $1,500 a dose, meaning the total cost during a pregnancy could be as much as $30,000.
That’s because the drug, a form of progesterone given as a weekly shot, has been made cheaply for years, mixed in special pharmacies that custom-compound treatments that are not federally approved.
But recently, KV Pharmaceutical of suburban St.Louis won government approval to exclusively sell the drug, known as Makena (Mah-KEE’-Nah). The March of Dimes and many obstetricians supported that because it means quality will be more consistent and it will be easier to get.
None of them anticipated the dramatic price hike, though _ especially since most of the cost for development and research was shouldered by others in the past.
“That’s a huge increase for something that can’t be costing them that much to make. For crying out loud, this is about making money,” said Dr. Roger Snow, deputy medical director for Massachusetts’ Medicaid program.
Doctors say the price hike may deter low-income women from getting the drug, leading to more premature births. And it will certainly be a huge financial burden for health insurance companies and government programs that have been paying for it.
The cost is justified to avoid the mental and physical disabilities that can come with very premature births, said KV Pharmaceutical chief executive Gregory J. Divis Jr. The cost of care for a preemie is estimated at $51,000 in the first year alone.
The U.S. Food and Drug Administration is not involved in setting the price for the drugs it approves.
But Snow and others said someone is going to have to pay the higher price. Some of the burden will fall on health insurance companies, which will have to raise premiums or other costs to their other customers. And some will fall on cash-strapped state Medicaid programs, which may be forced to stop paying for the drug or enroll fewer people.
TWT Video Picks
An America drowning in red ink is the land of the free no more
- David Jolly wins in Florida, GOP keeps swing district seat
- Kim Jong-un calls for execution of 33 Christians
- House Democrats trying to force unemployment insurance vote
- U.S. pilot scares off Iranians with 'Top Gun'-worthy stunt: 'You really ought to go home'
- Hillary Clinton campaign received funds from Jeffrey Thompson
- FCC targets black conservative in TV station fight
- Redskins bypass big splash - for now - as free agency period begins
- Senate Democrats, Republicans spar over restoring unemployment benefits
- CARNES: Kissinger's flawed and offensive analysis of Ukraine
- Sharyl Attkisson resigns from CBS after months of talks
Pope Francis meets his 'mini-me'
Celebrity deaths in 2014
Winter storm hits states — again